ImmunocorePlc-adr share price today

(IMCR)

ImmunocorePlc-adr share price is $28.33 & ₹2,407.37 as on 21 Dec 2024, 2.30 'hrs' IST

$28.33

▲

-0.1

(-0.33%)

Market is closed - opens 8 PM, 23 Dec 2024

View live ImmunocorePlc-adr share price in Dollar and Rupees. Guide to invest in ImmunocorePlc-adr from India. Also see the sentimental analysis on Indian investors investing in ImmunocorePlc-adr. Get details on the Indian mutual funds that are investing in ImmunocorePlc-adr. Get Analyst recommendations and forecasts along with all the ImmunocorePlc-adr's financials.

ImmunocorePlc-adr share price movements

Today's Low: $27.79
Today's High: $29.29
$28.33
1.91%
Downside
Day's Volatility :5.12%
Upside
3.28%
52 Weeks Low: $27.69
52 Weeks High: $76.98
$28.33
2.26%
Downside
52 Weeks Volatility :64.03%
Upside
63.2%

ImmunocorePlc-adr Returns

Period	Immunocore Holdings Plc-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-8.04%	-11.1%	0.0%
6 Months	-20.95%	-6.0%	0.0%
1 Year	-56.8%	2.7%	0.0%
3 Years	-17.66%	0.6%	-19.7%

ImmunocorePlc-adr Key Statistics

in dollars & INR

Previous Close	$28.42
Open	$28.7
Today's High	$29.29
Today's Low	$27.79
Market Capitalization	$1.4B
Today's Volume	$279.0K
52 Week High	$76.98
52 Week Low	$27.69
Revenue TTM	$296.3M
EBITDA	$-64.9M
Earnings Per Share (EPS)	$-0.95
Profit Margin	-15.88%
Quarterly Earnings Growth YOY	8.22%
Return On Equity TTM	-12.83%

How to invest in ImmunocorePlc-adr from India?

It is very easy for Indian residents to invest directly in ImmunocorePlc-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the ImmunocorePlc-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for ImmunocorePlc-adr or IMCR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of ImmunocorePlc-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of ImmunocorePlc-adr shares which would translate to 0.030 fractional shares of ImmunocorePlc-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like ImmunocorePlc-adr, in just a few clicks!

Returns in ImmunocorePlc-adr for Indian investors in Rupees

Investment Value

₹1,00,000

ImmunocorePlc-adr investment value today

Current value as on today

₹1,58,990

Returns

₹58,990

(+58.99%)

Returns from ImmunocorePlc-adr Stock

₹56,794 (false-56.79%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards ImmunocorePlc-adr

167%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for ImmunocorePlc-adr on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 167% more investors are searching ImmunocorePlc-adr in the last 30 days versus the previous period.

Global Institutional Holdings in ImmunocorePlc-adr

Wellington Management Company LLP
14.09%
T. Rowe Price Investment Management,Inc.
12.99%
RTW INVESTMENTS, LLC
9.73%
FMR Inc
9.67%
PRIMECAP Management Company
4.94%
T. Rowe Price Associates, Inc.
4.31%

Analyst Recommendation on ImmunocorePlc-adr

Buy

91%Buy

8%Hold

0%Sell

Based on 24 Wall street analysts offering stock ratings for ImmunocorePlc-adr(by analysts ranked 0 to 5 stars)

Based on 24 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on ImmunocorePlc-adr

What analysts predicted

Upside of 122.24%

Current:

$28.33

Target:

$62.96

Insights on ImmunocorePlc-adr

Price Movement
In the last 1 year, IMCR stock has moved down by -53.6%
Increasing Revenue
Revenue is up for the last 3 quarters, 70.50M → 80.24M (in $), with an average increase of 6.3% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -26.41M → 8.73M (in $), with an average increase of 117.2% per quarter
IMCR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 89.1%
IMCR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 41.2%
Price to Sales
ForIMCR every $1 of sales, investors are willing to pay $4.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

ImmunocorePlc-adr Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$30.0M	-
Net Income	$-90.7M	-
Net Profit Margin	-302.82%	-

	FY19	Y/Y Change
Revenue	$33.6M	↑ 8.52%
Net Income	$-136.1M	↑ 45.09%
Net Profit Margin	-404.89%	↓ 102.07%

	FY20	Y/Y Change
Revenue	$40.5M	↑ 17.32%
Net Income	$-99.5M	↓ 28.71%
Net Profit Margin	-246.04%	↑ 158.85%

	FY21	Y/Y Change
Revenue	$35.3M	↓ 11.93%
Net Income	$-175.0M	↑ 77.51%
Net Profit Margin	-495.94%	↓ 249.9%

	FY22	Y/Y Change
Revenue	$175.0M	↑ 441.99%
Net Income	$-50.2M	↓ 68.66%
Net Profit Margin	-28.68%	↑ 467.26%

	FY23	Y/Y Change
Revenue	$315.8M	↑ 73.53%
Net Income	$-70.0M	↑ 34.11%
Net Profit Margin	-22.17%	↑ 6.51%

	Q2 FY23	Q/Q Change
Revenue	$60.3M	↑ 7.24%
Net Income	$-17.8M	↓ 15.69%
Net Profit Margin	-29.47%	↑ 8.02%

	Q3 FY23	Q/Q Change
Revenue	$77.7M	↑ 31.11%
Net Income	$2.9M	↓ 116.45%
Net Profit Margin	3.7%	↑ 33.17%

	Q4 FY23	Q/Q Change
Revenue	$133.7M	↑ 68.68%
Net Income	$-33.4M	↓ 1240.71%
Net Profit Margin	-25.01%	↓ 28.71%

	Q1 FY24	Q/Q Change
Revenue	$89.6M	↓ 33.26%
Net Income	$-31.1M	↓ 7.5%
Net Profit Margin	-34.66%	↓ 9.65%

	Q2 FY24	Q/Q Change
Revenue	$75.4M	↑ 6.95%
Net Income	$-11.6M	↓ 52.46%
Net Profit Margin	-15.41%	↑ 19.25%

	Q3 FY24	Q/Q Change
Revenue	$80.2M	↑ 6.43%
Net Income	$8.7M	↓ 175.21%
Net Profit Margin	10.89%	↑ 26.3%

	FY18	Y/Y Change
Profit	$30.0M	-

	FY19	Y/Y Change
Profit	$-97.3M	↓ 414.2%

	FY20	Y/Y Change
Profit	$-60.0M	↓ 39.86%

	FY21	Y/Y Change
Profit	$-62.1M	↑ 4.5%

	FY22	Y/Y Change
Profit	$174.4M	↓ 406.78%

	FY23	Y/Y Change
Profit	$314.5M	↑ 73.36%

	Q2 FY23	Q/Q Change
Profit	$59.2M	↑ 5.67%

	Q3 FY23	Q/Q Change
Profit	$77.4M	↑ 33.02%

	Q4 FY23	Q/Q Change
Profit	$134.0M	↑ 69.8%

	Q1 FY24	Q/Q Change
Profit	$89.3M	↓ 33.65%

	Q2 FY24	Q/Q Change
Profit	$73.7M	↑ 4.89%

	Q3 FY24	Q/Q Change
Profit	$79.8M	↑ 8.29%

	FY18	Y/Y Change
Operating Cash Flow	$-21.1M	↓ 72.71%
Investing Cash Flow	$73.5M	↓ 703.68%
Financing Cash Flow	$127.9K	↓ 99.47%

	FY19	Y/Y Change
Operating Cash Flow	$-132.7M	↑ 509.74%
Investing Cash Flow	$-5.4M	↓ 107.13%
Financing Cash Flow	$72.2M	↑ 54481.19%

	FY20	Y/Y Change
Operating Cash Flow	$-81.4M	↓ 40.25%
Investing Cash Flow	$627.3K	↓ 111.29%
Financing Cash Flow	$155.7M	↑ 110.32%

	FY21	Y/Y Change
Operating Cash Flow	$-172.6M	↑ 114.2%
Investing Cash Flow	$-488.3K	↓ 178.59%
Financing Cash Flow	$367.5M	↑ 138.27%

	FY22	Y/Y Change
Operating Cash Flow	$-38.1M	↓ 75.9%
Investing Cash Flow	$234.9K	↓ 152.59%
Financing Cash Flow	$168.3M	↓ 49.96%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.0M	↓ 127.2%
Investing Cash Flow	$3.4M	↑ 0.0%
Financing Cash Flow	$9.3M	↑ 196.1%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$7.7M	↓ 360.35%
Investing Cash Flow	$2.7M	↓ 20.88%
Financing Cash Flow	$9.7M	↑ 6.11%

ImmunocorePlc-adr Technicals Summary

Sell

Neutral

Buy

ImmunocorePlc-adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

ImmunocorePlc-adr Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Immunocore Holdings Plc-adr	-11.82%	-20.95%	-56.8%	-17.66%	-28.53%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Immunocore Holdings Plc-adr	NA	NA	NA	-0.56	-0.13	-0.05	NA	7.55
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Immunocore Holdings Plc-adr	Buy	$1.4B	-28.53%	NA	-15.88%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About ImmunocorePlc-adr

immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. its world-leading t cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells. immunocore has established a robust technology platform which combines monoclonal t cell receptor (mtcr) targeting technology with an effector technology, anti-cd3 scfv, that catalyses the killing of the targeted diseased cells by the host’s own non-specific cytotoxic t cells. immunocore is developing a portfolio of products from the platform, called immtacs, for the treatment of cancer, chronic infectious disease and diabetes.

Organization	ImmunocorePlc-adr
Employees	497
CEO	Dr. Bahija Jallal Ph.D.
Industry	Services

Management People of ImmunocorePlc-adr

Name	Title
Dr. Bahija Jallal Ph.D.	CEO & Executive Director
Mr. Brian R. Di Donato M.B.A.	Executive VP, CFO & Strategy
Ms. Tina St. Leger	Chief Human Resources Officer
Dr. David Berman M.D., Ph.D.	Executive Vice President of Research & Development
Mr. John Trainer M.B.A.	SVP & Chief Operating Officer
Mr. John Goll III	SVP, Finance & Chief Accounting Officer
Ms. Annelise Vuidepot Ph.D.	Senior VP, CTO and Research & UK Site Lead
Mr. Sean D. Buckley	VP & Chief Information Officer
Clayton Robertson	Head of Investor Relations
Ms. Lily Margaret Hepworth	Senior VP, General Counsel & Company Secretary

Important FAQs about investing in ImmunocorePlc-adr from India :

What is ImmunocorePlc-adr share price today?

ImmunocorePlc-adr share price today stands at $28.33, Open: $28.70 ; Previous Close: $28.42 ; High: $29.29 ; Low: $27.79 ; 52 Week High: $76.98 ; 52 Week Low: $27.69. The stock opens at $28.70, after a previous close of $28.42. The stock reached a daily high of $29.29 and a low of $27.79, with a 52-week high of $76.98 and a 52-week low of $27.69.

Can Indians buy ImmunocorePlc-adr shares?

Yes, Indians can invest in the ImmunocorePlc-adr (IMCR) from India.

With INDmoney, you can buy ImmunocorePlc-adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy ImmunocorePlc-adr at zero transaction cost.

How can I buy ImmunocorePlc-adr shares from India?

It is very easy to buy ImmunocorePlc-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of ImmunocorePlc-adr be purchased?

Yes, you can buy fractional shares of ImmunocorePlc-adr with INDmoney app.

What are the documents required to start investing in ImmunocorePlc-adr stocks?

To start investing in ImmunocorePlc-adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.